Hazelnuts: Vitamin E, Heart Health, and Antioxidant Depth

How hazelnuts protect LDL cholesterol from oxidation, lower cardiovascular risk biomarkers, and deliver the highest vitamin E content of any common nut

Hazelnuts are among the most nutrient-dense nuts available, delivering more vitamin E per serving than any other common tree nut and providing a fat profile dominated by oleic acid — the same monounsaturated fatty acid found in olive oil. Clinical trials consistently show that eating a handful of hazelnuts daily lowers LDL cholesterol, reduces oxidized LDL (the form linked to artery damage), and improves total cardiovascular risk markers without causing weight gain [1][2]. The combination of tocopherols, proanthocyanidins, and oleic acid makes hazelnuts effective not just as a lipid-lowering food but as a genuinely cardioprotective one.

Why Hazelnuts Stand Out Among Tree Nuts

A one-ounce serving of hazelnuts (about 21 nuts, 28 grams) provides roughly 4 mg of alpha-tocopherol — the most bioavailable form of vitamin E — which covers about 27% of the daily value. For context, almonds are often cited as a vitamin E source, but hazelnuts contain comparable or higher amounts depending on the preparation. Vitamin E is a fat-soluble antioxidant that sits inside cell membranes and lipoproteins, specifically protecting against oxidation. This matters most in the context of LDL cholesterol: oxidized LDL, not LDL itself, is the form that triggers plaque formation in artery walls.

The fat content of hazelnuts is about 86% unsaturated, with oleic acid making up 75–80% of total fat. This profile is nearly identical to that of olive oil and avocado, two foods with strong cardiovascular evidence. Oleic acid improves the ratio of LDL to HDL cholesterol, reduces inflammatory markers, and does not raise triglycerides the way saturated or refined carbohydrate intake can.

Hazelnuts also contain substantial proanthocyanidins — a class of polyphenols that give them their slightly astringent quality. By USDA measurement, hazelnuts have among the highest proanthocyanidin content of any food, including many berries. These compounds act as antioxidants, inhibit platelet aggregation, and have been associated with improved vascular function in laboratory and observational research.

Cardiovascular and Lipid Effects

Human trials using 29–69 grams of hazelnuts per day (roughly one to two handfuls) for 28–84 days consistently show reductions in total cholesterol, LDL cholesterol, and triglycerides, with modest increases in HDL. A 2016 meta-analysis of nine intervention studies found statistically significant reductions in total cholesterol (weighted mean difference −0.26 mmol/L) and LDL cholesterol (−0.22 mmol/L) with hazelnut consumption [1]. Importantly, no study found meaningful weight gain despite the high caloric density, likely because the fat and fiber content increase satiety and reduce intake at other meals.

Beyond lipid numbers, a Turkish clinical trial found that a hazelnut-enriched diet lowered not just cholesterol but also oxidized LDL, C-reactive protein (a marker of systemic inflammation), and endothelin-1 (a marker of endothelial dysfunction) in hypercholesterolemic subjects [2]. This suggests the protection extends beyond simple cholesterol reduction to actual vascular biology.

Vitamin E, Antioxidant Status, and Gene Expression

A pre-post intervention study in healthy older adults (average age 63) found that eating approximately 57 grams of hazelnuts per day for 16 weeks significantly increased serum alpha-tocopherol and its urinary metabolite, confirming that the vitamin E in hazelnuts is bioavailable and does accumulate in tissue [4]. The same study found decreases in fasting glucose and improvements in the lipid profile, suggesting metabolic benefits beyond antioxidant status alone.

Separately, a pilot trial in 24 healthy volunteers consuming 40 grams of hazelnuts daily for six weeks showed significant upregulation of antioxidant and anti-inflammatory genes — including those encoding catalase and superoxide dismutase — without any increase in body weight [5]. Gene expression changes of this kind suggest that regular hazelnut intake is doing something at the cellular level beyond what nutrient profiles alone would predict.

Practical Considerations

Raw or dry-roasted hazelnuts both preserve their nutritional value well; light roasting does not significantly degrade tocopherol content. Hazelnuts are relatively low in phytic acid compared to some other nuts, which means the mineral content — manganese (nearly 2 mg per ounce, covering most of the daily requirement), copper, folate, and magnesium — is reasonably well absorbed without soaking. For people who prefer soaking nuts to reduce antinutrients, there is no harm in doing so, though it is less critical with hazelnuts than with almonds or cashews.

A practical serving is one to two handfuls (28–56 grams) per day. This aligns with the doses used in clinical trials and is enough to see lipid and antioxidant effects within four to twelve weeks of consistent use.

See our Walnuts page for research on omega-3 fatty acids and brain health, or the Almonds page for their prebiotic fiber effects.

Evidence Review

Meta-analysis: Lipid Effects (Perna et al., 2016) [1]

Perna and colleagues pooled data from nine controlled intervention studies involving 425 participants consuming 29 to 69 grams of hazelnuts per day for 28 to 84 days. The primary outcome was change in blood lipid parameters. Results showed statistically significant reductions in total cholesterol (weighted mean difference −0.26 mmol/L, 95% CI: −0.47 to −0.06, p=0.012) and LDL cholesterol (WMD −0.22 mmol/L, 95% CI: −0.35 to −0.09, p=0.001). Triglycerides were also reduced, and HDL showed a non-significant upward trend. Body weight did not increase in any of the nine trials. Limitations include small sample sizes in individual trials, short durations, and heterogeneity in hazelnut form (raw, roasted, blanched). However, the consistency of findings across multiple study designs strengthens confidence in the lipid-lowering effect.

Cardiovascular Biomarkers Beyond Lipids (Orem et al., 2013) [2]

This Turkish randomized controlled trial enrolled hypercholesterolemic adults and assigned them to a hazelnut-enriched diet for four weeks. The hazelnut group showed reductions in total cholesterol (−7.8%), LDL cholesterol (−6.2%), and triglycerides (−7.3%), with an increase in HDL cholesterol (6.1%). More notably, the study measured vascular biomarkers: oxidized LDL fell significantly in the hazelnut group (p<0.05), as did endothelin-1, a peptide involved in vasoconstriction that is elevated in early atherosclerosis. C-reactive protein also declined, suggesting systemic anti-inflammatory effects. This combination — reduced lipid oxidation, reduced inflammatory tone, and improved endothelial markers — distinguishes hazelnuts from purely lipid-lowering interventions.

Bioavailability of Vitamin E (Tey et al., 2011) [3]

Tey and colleagues conducted a crossover trial in 48 mildly hypercholesterolemic adults comparing three forms of hazelnuts (ground, sliced, whole) at doses calculated to replace 15% of total energy intake. All three forms produced equivalent improvements in serum alpha-tocopherol concentrations and lipid profiles, demonstrating that hazelnut cell wall structure does not substantially limit vitamin E absorption. The study also found no significant differences in blood glucose or insulin, suggesting that regular hazelnut consumption is metabolically safe in this population.

Vitamin E Status in Older Adults (Michels et al., 2018) [4]

This pre-post study in 32 older adults (mean age 63 ± 6 years) measured both serum alpha-tocopherol and its primary urinary metabolite (alpha-CEHC) after 16 weeks of consuming approximately 57 grams of Oregon hazelnuts per day. Urinary alpha-CEHC increased significantly, confirming that vitamin E from hazelnuts saturates tissue stores and the excess is excreted — a marker of adequate vitamin E status. Serum magnesium improved, fasting glucose declined, and LDL and total cholesterol decreased. The use of an older adult population is notable because vitamin E deficiency risk increases with age, and dietary sources are preferable to supplemental alpha-tocopherol, which at high doses may paradoxically increase oxidative stress.

Antioxidant and Anti-inflammatory Gene Expression (Di Renzo et al., 2019) [5]

This prospective pilot trial in 24 healthy volunteers assessed changes in gene expression related to oxidative stress and inflammation after six weeks of eating 40 grams of hazelnuts daily. The hazelnut-enriched diet significantly upregulated genes encoding catalase (an antioxidant enzyme), superoxide dismutase 1, and heme oxygenase-1, while downregulating inflammatory markers including interleukin-1 beta and COX-2. Body weight, BMI, and waist circumference did not change. While the sample size is small and the pilot designation limits conclusions, the mechanistic findings provide a plausible pathway for hazelnuts' observed cardiovascular effects: modulation of cellular redox balance and reduced inflammatory signaling at the gene level.

Overall Evidence Assessment

The evidence for hazelnuts' lipid-lowering and antioxidant effects is moderate-to-strong, supported by a meta-analysis and multiple independent trials. The range of doses studied (29–69 g/day) is practical for daily consumption, and the consistently observed absence of weight gain addresses a common barrier to nut consumption. Evidence is weaker for effects on blood glucose and inflammation, where studies are smaller and shorter. The vitamin E bioavailability data is robust and clinically relevant, particularly for older adults and those with fat-malabsorption issues. No studies have assessed long-term cardiovascular outcomes (e.g., myocardial infarction rates), which remains a gap in the hazelnut-specific literature, though nut consumption broadly is associated with lower cardiovascular mortality in large prospective cohorts.

References

Effects of Hazelnut Consumption on Blood Lipids and Body Weight: A Systematic Review and Meta-AnalysisPerna S, Giacosa A, Bonitta G, Bologna C. Nutrients, 2016. PubMed 27897978 →
Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjectsOrem A, Yucesan FB, Orem C, Akcan B. Journal of Clinical Lipidology, 2013. PubMed 23415431 →
Effects of different forms of hazelnuts on blood lipids and alpha-tocopherol concentrations in mildly hypercholesterolemic individualsTey SL, Brown RC, Chisholm AW, Delahunty CM. European Journal of Clinical Nutrition, 2011. PubMed 20877394 →
Daily Consumption of Oregon Hazelnuts Affects alpha-Tocopherol Status in Healthy Older Adults: A Pre-Post Intervention StudyMichels AJ, Leonard SW, Uesugi SL, Bobe G. The Journal of Nutrition, 2018. PubMed 30517727 →
A Hazelnut-Enriched Diet Modulates Oxidative Stress and Inflammation Gene Expression without Weight GainDi Renzo L, Cioccoloni G, Bernardini S, Abenavoli L. Oxidative Medicine and Cellular Longevity, 2019. PubMed 31354906 →